Interferon-beta treatment and the natural history of relapsing-remitting multiple sclerosis

Ann Neurol. 2008 Jan;63(1):125-6; author reply 126-7. doi: 10.1002/ana.21185.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Clinical Trials as Topic / standards*
  • Clinical Trials as Topic / statistics & numerical data
  • Comorbidity
  • Humans
  • Immunologic Factors / therapeutic use*
  • Immunotherapy / methods*
  • Immunotherapy / trends
  • Interferon-beta / therapeutic use*
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Multiple Sclerosis, Relapsing-Remitting / immunology
  • Multiple Sclerosis, Relapsing-Remitting / physiopathology
  • Outcome Assessment, Health Care
  • Patient Compliance / statistics & numerical data
  • Recurrence
  • Reproducibility of Results
  • Selection Bias
  • Withholding Treatment / statistics & numerical data

Substances

  • Immunologic Factors
  • Interferon-beta